Top Story

Mortality rates decrease for adult hypertrophic cardiomyopathy

Mortality rates decrease for adult hypertrophic cardiomyopathy
May 6, 2015

Study findings of long-term outcomes in adults with hypertrophic cardiomyopathy found that disease-related mortality rates have dropped to approximately 0.5% per year due to advances in management of and treatments for the condition.

Adult-onset hypertrophic cardiomyopathy has traditionally been associated with annual mortality rates of up to 6% due to complications, including sudden death and death from HF, according to the study background.

Salim S. Virani, MD PhD, FACC, FAHA Meeting News Coverage

Outpatient CVD care delivery similar between physician, nonphysician primary care providers

May 5, 2015
The quality of care for patients with CVD provided by primary care physicians, nurse practitioners and physician assistants in the outpatient setting is comparable…
In the Journals

Insulin resistance increases CVD risk in postmenopausal women without diabetes

May 5, 2015
Postmenopausal women with measures of insulin resistance or impaired fasting glucose have an increased risk for cardiovascular disease even if they do not have diabetes…
FDA News

FDA clears balloon dilatation catheter

May 5, 2015
Medtronic announced that the FDA has granted 510(k) clearance to its Euphora semicompliant balloon dilatation catheter, a pre-dilatation therapy used during stent…
Karen E. Joynt, MD, MPH In the Journals

Electronic health records not associated with better outcomes in stroke care

May 5, 2015
Electronic health records were not associated with higher-quality care or better clinical outcomes for stroke care in a study of hospitals in the Get With the…
More News Headlines »
CME
Debating the Differences and Nuances of Antiplatelet Therapy in ACS and PCI: Not a One-Size-Fits-All?

Debating the Differences and Nuances of Antiplatelet Therapy in ACS and PCI: Not a One-Size-Fits-All?

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

More »
Meeting News Coverage Video
VIDEO: Nathaniel Reichek, MD, shares insights on impact of PROMISE trial data

VIDEO: Nathaniel Reichek, MD, shares insights on impact of PROMISE trial data

May 3, 2015
SAN DIEGO — Nathaniel Reichek, MD, director of cardiac imaging services at St. Francis Hospital, Roslin, NY and…
More »
CME
Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

This activity is supported by an educational grant from AstraZeneca.

Hypertriglyceridemia is a highly prevalent, yet modifiable, risk factor for atherosclerotic disease, pancreatitis, and…
More »